NEW YORK (GenomeWeb News) – The National Institute on Drug Abuse plans to fund research that will use epigenomics approaches to study HIV and how it is linked to substance abuse, the National Institutes of Health said in a notice posted on its website.
NIDA expects to fund "a broad range of interdisciplinary research, using in vitro, animal and human approaches to address these interactions," NIH said.
The R01 and the R21 grants could fund epigenomics regulation of HIV infection, epigenomics processes associated with specific patterns of disease progression in individuals with a history of substance abuse, and the effects of epigenomics changes associated with drug abuse on HIV infection and disease progression.
These studies must focus on HIV/AIDS, and they must have a significant epigenomics or non-coding RNA component, and must include a component related to drugs of abuse.
Studies that use samples from drug-abusing populations or in vivo or in vitro model systems would be appropriate for these grants, NIH said.
NIH expects to publish the RFA in September with an expected receipt date in December.